KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage - WSJ

1. KKR proposes to acquire remaining shares of Biotage for $1.2 billion. 2. The offer includes a 60% premium over Biotage's recent stock price. 3. KKR aims to enhance Biotage's growth in a private setting. 4. KKR already holds a 17% stake in Biotage via Gamma Biosciences. 5. Biotage's board supports KKR's acquisition offer.